Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of BioNumerik Pharmaceuticals patents

Patents where

Current Assignee

Name

BioNumerik Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7238823 Platinum complexes with mononitrile-containing ligands	Patent 7238823 was granted and assigned to BioNumerik Pharmaceuticals on July, 2007 by the United States Patent and Trademark Office.		BioNumerik Pharmaceuticals	United States Patent and Trademark Office	7238823	July 3, 2007
‌ US Patent 7176192 Method for treating patients for radiation exposure	Patent 7176192 was granted and assigned to BioNumerik Pharmaceuticals on February, 2007 by the United States Patent and Trademark Office.		BioNumerik Pharmaceuticals	United States Patent and Trademark Office	7176192	February 13, 2007
‌ US Patent 7282602 Medicinal disulfide salts	Patent 7282602 was granted and assigned to BioNumerik Pharmaceuticals on October, 2007 by the United States Patent and Trademark Office.		BioNumerik Pharmaceuticals	United States Patent and Trademark Office	7282602	October 16, 2007
‌ US Patent 7687497 C10-substituted camptothecin analogs	Patent 7687497 was granted and assigned to BioNumerik Pharmaceuticals on March, 2010 by the United States Patent and Trademark Office.		BioNumerik Pharmaceuticals	United States Patent and Trademark Office	7687497	March 30, 2010
‌ US Patent 8722886 Methods for the total chemical synthesis of enantiomerically-pure 7-(2′-trimethylsilyl)ethyl camptothecin	Patent 8722886 was granted and assigned to BioNumerik Pharmaceuticals on May, 2014 by the United States Patent and Trademark Office.		BioNumerik Pharmaceuticals	United States Patent and Trademark Office	8722886	May 13, 2014
‌ US Patent 7759488 Monoazole ligand platinum analogs	Patent 7759488 was granted and assigned to BioNumerik Pharmaceuticals on July, 2010 by the United States Patent and Trademark Office.		BioNumerik Pharmaceuticals	United States Patent and Trademark Office	7759488	July 20, 2010
‌ US Patent 7829538 Compounds and methods for reducing undesired toxicity of chemotherapeutic agents	Patent 7829538 was granted and assigned to BioNumerik Pharmaceuticals on November, 2010 by the United States Patent and Trademark Office.		BioNumerik Pharmaceuticals	United States Patent and Trademark Office	7829538	November 9, 2010
‌ US Patent 7829539 Compounds and methods for reducing undesired toxicity of chemotherapeutic agents	Patent 7829539 was granted and assigned to BioNumerik Pharmaceuticals on November, 2010 by the United States Patent and Trademark Office.		BioNumerik Pharmaceuticals	United States Patent and Trademark Office	7829539	November 9, 2010
‌ US Patent 7829117 Compounds and methods for reducing undesired toxicity of chemotherapeutic agents	Patent 7829117 was granted and assigned to BioNumerik Pharmaceuticals on November, 2010 by the United States Patent and Trademark Office.		BioNumerik Pharmaceuticals	United States Patent and Trademark Office	7829117	November 9, 2010
‌ US Patent 7687487 Camptothecin-analog with a novel, “flipped” lactone-stable, E-ring and methods for making and using same	Patent 7687487 was granted and assigned to BioNumerik Pharmaceuticals on March, 2010 by the United States Patent and Trademark Office.		BioNumerik Pharmaceuticals	United States Patent and Trademark Office	7687487	March 30, 2010
‌ US Patent 9023805 Increasing cancer patient survival time by administration of dithio-containing compounds	Patent 9023805 was granted and assigned to BioNumerik Pharmaceuticals on May, 2015 by the United States Patent and Trademark Office.		BioNumerik Pharmaceuticals	United States Patent and Trademark Office	9023805	May 5, 2015
‌ US Patent 7687496 C7-substituted camptothecin analogs	Patent 7687496 was granted and assigned to BioNumerik Pharmaceuticals on March, 2010 by the United States Patent and Trademark Office.		BioNumerik Pharmaceuticals	United States Patent and Trademark Office	7687496	March 30, 2010
‌ US Patent 8026227 Chemoprotective methods and compositions	Patent 8026227 was granted and assigned to BioNumerik Pharmaceuticals on September, 2011 by the United States Patent and Trademark Office.		BioNumerik Pharmaceuticals	United States Patent and Trademark Office	8026227	September 27, 2011
‌ US Patent 9320760 Compositions and methods of use of compounds to increase cancer patient survival time	Patent 9320760 was granted and assigned to BioNumerik Pharmaceuticals on April, 2016 by the United States Patent and Trademark Office.		BioNumerik Pharmaceuticals	United States Patent and Trademark Office	9320760	April 26, 2016
‌ US Patent 7268244 Monoimine ligand platinum analogs	Patent 7268244 was granted and assigned to BioNumerik Pharmaceuticals on September, 2007 by the United States Patent and Trademark Office.		BioNumerik Pharmaceuticals	United States Patent and Trademark Office	7268244	September 11, 2007
‌ US Patent 7777060 Platinum analogs with bis-nitrile-containing ligands	Patent 7777060 was granted and assigned to BioNumerik Pharmaceuticals on August, 2010 by the United States Patent and Trademark Office.		BioNumerik Pharmaceuticals	United States Patent and Trademark Office	7777060	August 17, 2010
‌ US Patent 7829541 Compounds and methods for reducing undesired toxicity of chemotherapeutic agents	Patent 7829541 was granted and assigned to BioNumerik Pharmaceuticals on November, 2010 by the United States Patent and Trademark Office.		BioNumerik Pharmaceuticals	United States Patent and Trademark Office	7829541	November 9, 2010
‌ US Patent 8143236 Chemoprotective methods	Patent 8143236 was granted and assigned to BioNumerik Pharmaceuticals on March, 2012 by the United States Patent and Trademark Office.		BioNumerik Pharmaceuticals	United States Patent and Trademark Office	8143236	March 27, 2012
‌ US Patent 8710095 Drugs for prophylaxis or mitigation of taxane-induced neurotoxicity	Patent 8710095 was granted and assigned to BioNumerik Pharmaceuticals on April, 2014 by the United States Patent and Trademark Office.		BioNumerik Pharmaceuticals	United States Patent and Trademark Office	8710095	April 29, 2014
‌ US Patent 10413538 Administration of karenitecin for the treatment of platinum and/or taxane chemotherapy-resistant or -refractory advanced ovarian cancer	Patent 10413538 was granted and assigned to BioNumerik Pharmaceuticals on September, 2019 by the United States Patent and Trademark Office.	BioNumerik Pharmaceuticals	BioNumerik Pharmaceuticals	United States Patent and Trademark Office	10413538	September 17, 2019
‌ US Patent 7569606 Platinum complexes with mononitrile-containing ligands	Patent 7569606 was granted and assigned to BioNumerik Pharmaceuticals on August, 2009 by the United States Patent and Trademark Office.		BioNumerik Pharmaceuticals	United States Patent and Trademark Office	7569606	August 4, 2009
‌ US Patent 7829540 Compounds and methods for reducing undesired toxicity of chemotherapeutic agents	Patent 7829540 was granted and assigned to BioNumerik Pharmaceuticals on November, 2010 by the United States Patent and Trademark Office.		BioNumerik Pharmaceuticals	United States Patent and Trademark Office	7829540	November 9, 2010
‌ US Patent 8569265 Deuterated analogs of (4S)-4-ethyl-4-hydroxy-11-[2- (trimethylsilyl)ethyl]-1H-pyrano[3′, 4′:6,7] indolizino [1,2-b]quinoline-3,14(4H, 12H)-dione and methods of use thereof	Patent 8569265 was granted and assigned to BioNumerik Pharmaceuticals on October, 2013 by the United States Patent and Trademark Office.		BioNumerik Pharmaceuticals	United States Patent and Trademark Office	8569265	October 29, 2013
‌ US Patent 6936733 Method for preparing disodium 2,2'-dithiobis(ethanesulphonate)	Patent 6936733 was granted and assigned to BioNumerik Pharmaceuticals on August, 2005 by the United States Patent and Trademark Office.		BioNumerik Pharmaceuticals	United States Patent and Trademark Office	6936733	August 30, 2005
‌ US Patent 7030243 Process for making camptothecin derivatives	Patent 7030243 was granted and assigned to BioNumerik Pharmaceuticals on April, 2006 by the United States Patent and Trademark Office.		BioNumerik Pharmaceuticals	United States Patent and Trademark Office	7030243	April 18, 2006

Results per page:

28 results

0 selected

28 results

0 selected